Optimized Reverse Transfection Protocol For Telomerase Mrna Delivery To Early-Senescent Human Fibroblasts
Our cells have protective caps on the ends of their chromosomes, called telomeres, which naturally shorten each time a cell divides. Once these telomeres become too short, cells stop dividing and enter a state of aging known as senescence. This natural process limits how many times our cells can multiply, which can be a challenge for medical research and therapies that require a large number of healthy cells.
Researchers have found a way to temporarily reverse this cellular aging by delivering a special genetic message, known as messenger RNA (mRNA), into human cells. This mRNA carries instructions for making an enzyme called telomerase, which is responsible for maintaining and extending telomeres. By introducing this mRNA, the cells transiently produce telomerase, leading to a rapid lengthening of their telomeres.
This innovative approach allowed human cells, specifically fibroblasts (a common type of cell found in connective tissue), to undergo significantly more divisions than they normally would. Importantly, this method is non-viral and non-integrating, meaning it doesn’t permanently alter the cell’s own genetic material, thus avoiding potential risks like insertional mutagenesis (where new genetic material disrupts existing genes). This breakthrough could have broad applications in disease modeling, drug discovery, and regenerative medicine, by providing a way to produce large quantities of healthy, functional human cells.
Source: link to paper